About this trial
The demand for prevention and treatment of adolescent depression has rapidly increased over years. A national project to improve treatment of adolescent depression in primary care has taken place in Finland starting 2020.
The goal of this prospective observational cohort study is to describe pathways to mental health services in adolescents with depressive symptoms. The main questions it aims to answer are:
* Do young people reporting depressive symptoms have equal access to treatment? * How is it best to recognize those adolescents who will benefit from IPC-A?
Adolescents who participate in the study will
* complete a survey on protective and risk factors of depression three times over 6 months * report possible depressive symptoms every two weeks over 6 months * report whether they needed and received help, motivation for treatment, and benefits and harms from treatment
We will also collect
* information from one of caretakers with two surveys within 6 month- intervals on their view on adolescent's need for support, strengths and risks, and benefits and harms from treatment where applicable * where applicable, from the professional who provided support after the intervention on their training and competence, as well as content of and response to treatment * register data to estimate overall provision and cost of social welfare and health care services one year preceding the study and over 2 to 10 years after the observation period
Researchers will compare an intervention that is new in Finland, adolescent interpersonal counseling (IPC-A), to other treatments of depression, to see if it is equal to or better than other treatments of depression.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
we will include all adolescents attending grades 7 to 9 in selected schools with on informed consent
Disqualifiers
psychiatric care within the past 12 months or receiving a psychosocial intervention (psychotherapy, IPC-A, any other therapy of support) during the 12 months before baseline,
an inability to reliably understand the Finnish, Plain Finnish, Swedish, or English versions of the survey, or
an adolescents' or caretakers' report of a need for exclusion, such as another medical condition - including a mental disorder - requiring acute current treatment or support.
Trial population
Adolescents attending grades 7 to 9 (13 to 16 years) in selected schools
Trial design
Ecologic or community
Prospective
Treatments tested in this trial
Interpersonal counseling
BehavioralA structured psychotherapeutic intervention to prevent depression or treat mild to moderate depression. IPC-A is a brief, individual-based intervention (3-8 sessions). The focus is on interpersonal relations as a factor of resilience in depressive symptoms. IPC-A is a shorter form of IPT-A, developed by prof. Myrna Weissman and team.
Treatment as usual
BehavioralAny other behavioral or medical support or depression indicated by depressive symptoms or depression. This is based on adolescent, caretaker and professional's report.
No support, intervention or other treatment
Other interventionThe group will comprise those adolescents who report sustained depression but do not seek or receive support over 6 months of follow-up based on adolescent and caretaker's report
Treatment groups
Trial outcomes
Primary outcomes
Proportion of adolescents referred to specialized psychiatric services
Proportion of adolescents in each three groups with sustained depressive symptoms by 6 months who receive specialized psychiatric services by 12 months
Secondary outcomes
Proportion of adolescents who received any social welfare or health care services
Data collected from adolescent and caretaker's surveys and registers
longitudinal changes in PHQ-9-A score
Longitudinal changes in biweekly PHQ-9-A scores over 6 months; PHQ-9-A 10 items, 0 to 3, higher score more depression
Other outcomes
Loneliness
One item: Do you feel lonely? yes/no
Experiences of Social Inclusion Scale
10 items, 0 to 4, higher score more inclusion
The child-friendly EuroQol-5 dimensions questionnaire
EQ-5D-Y, 5 items 0 to 2; a VAS scale, higher score more functional
Generalized Anxiety Disorder Scale-7
GAD-7, 7 items 0 to 3, higher score more anxiety
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Finnish Institute for Health and Welfare
Lead sponsor
Strategic Research Council of Finland
Collaborator
University of Helsinki
Collaborator
University of Eastern Finland
Collaborator
Tampere University
Collaborator